OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 131 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,000 | -27.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | -67.6% | 20,000 | 0.0% | 0.00% | – |
| Q4 2015 | $34,000 | -22.7% | 20,000 | -4.8% | 0.00% | – |
| Q3 2015 | $44,000 | -55.6% | 21,000 | +5.0% | 0.00% | -100.0% |
| Q2 2015 | $99,000 | -36.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $156,000 | +28.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $121,000 | +188.1% | 20,000 | +100.0% | 0.00% | – |
| Q3 2014 | $42,000 | -99.8% | 10,000 | -99.6% | 0.00% | -100.0% |
| Q2 2014 | $17,366,000 | -36.5% | 2,810,055 | -33.3% | 0.11% | -38.9% |
| Q1 2014 | $27,365,000 | -2.0% | 4,210,055 | -15.2% | 0.18% | -2.7% |
| Q4 2013 | $27,934,000 | -13.2% | 4,961,790 | -5.5% | 0.18% | -17.8% |
| Q3 2013 | $32,170,000 | -31.3% | 5,247,990 | -14.6% | 0.22% | -30.1% |
| Q2 2013 | $46,860,000 | – | 6,141,636 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |